Tempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.

Multiple factors could get in the way of confirming a new commissioner before the midterm elections, experts said, leaving ...

An upcoming Medicare coverage decision for transcatheter aortic valve replacement devices and study readout for patients with ...

While Johnson & Johnson will go head to head with Intuitive in the U.S., analysts questioned whether its robotic surgery ...

Andrew Aberdale will help expand AiM’s strategic partnership ecosystem, including its recent collaboration with Siemens ...

Shareholders approved a plan to dissolve the robot developer, at one time a well-financed contender to challenge surgical ...

The deal is the latest in a series of pacts that GE HealthCare has made with health systems, including with Sutter Health and ...

The computing platform will make its debut at the Society of Robotic Surgery meeting this week, as Medtronic challenges ...

The supply of the circuit boards needed to fix the devices is significantly constrained, preventing the company from ...

Whoop on Wednesday named Ami Bhatt as the company’s new chief medical officer, as the wearables firm makes a broader push ...

Philips said its updated device provides accurate readings across a range of skin tones, following concerns that pulse ...

Selected devices will be exempt from certain premarket requirements while manufacturers collect real-world data through Medicare.